• Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ALNOV:FP

5.0700 EUR 0.1500 2.87%

As of 06:43:07 ET on 12/24/2014.

Snapshot for Novacyt (ALNOV)

Open: 5.2000 Day's Range: 5.0400 - 5.2000 Volume: 263
Previous Close: 5.2200 52wk Range: 4.0000 - 7.5000 1-Yr Rtn: -34.92%

Stock Chart for ALNOV

No chart data available.
  • ALNOV:FP 5.0700
  • 1D
  • 1M
  • 1Y
5.2200
Interactive ALNOV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ALNOV

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. CAC -
Earnings Per Share (EUR) (ttm) -0.3550
Est. EPS (EUR) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 31.14
Shares Outstanding (M) 6.14
30 Day Average Volume 763
Price/Book (mrq) -
Price/Sale (ttm) 12.2928
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/02/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ALNOV

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ALNOV

Novacyt has developed and commercializes a cancer screening solution in the field of liquid based cytology.

Eric PeltierChairman/CEO/Co-FounderJean-Pierre CrinelliCOO/Co-Founder
More Company Profile & Key Executives for ALNOV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil